New Key Statistics Module, Z-Score and F-Score
TSXV:NPTH Key Ratios
Market Cap C$ M | 10.43 |
Enterprise Value C$ M | 19.23 |
P/E(ttm) | 61.67 |
PE Ratio without NRI | 92.50 |
Forward PE Ratio | -- |
Price/Book | 0.47 |
Price/Sales | 0.15 |
Price/Free Cash Flow | 5.61 |
Price/Owner Earnings | 6.13 |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 69.00 |
EPS (TTM) C$ | 0.003 |
Beneish M-Score | -2.79 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 842.90 |
EV-to-EBIT | 15.61 |
EV-to-EBITDA | 5.16 |
PEG | -- |
Shares Outstanding M | 56.39 |
Net Margin (%) | -0.11 |
Operating Margin % | 1.44 |
Pre-tax Margin (%) | 0.36 |
Quick Ratio | 1.03 |
Current Ratio | 1.03 |
ROA % (ttm) | -0.18 |
ROE % (ttm) | -0.34 |
ROIC % (ttm) | 0.07 |
Dividend Yield % | -- |
Altman Z-Score | 1.21 |
TSXV:NPTH Number of Guru Trades
TSXV:NPTH Volume of Guru Trades
Gurus Latest Trades with TSXV:NPTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:NPTH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NeuPath Health Inc Insider Transactions
No Available Data